Vogue spotlights Scientific Director Nir Barzilai, MD, and Board Member David Sinclair, PhD, in feature on Metformin and healthspan.
![Vogue spotlights Scientific Director Nir Barzilai, MD, and Board Member David Sinclair, PhD, in feature on Metformin and healthspan.]()
On November 27, 2023, Vogue featured the insights of AFAR Scientific Director Nir Barzilai, MD, and Board Member David A. Sinclair, PhD, AO, in an article examining the potential of the drug Metformin to extend healthspan.
The TAME (Targeting Aging with Metformin) Trial, which AFAR has been helping raise funds to launch, is also discussed.
Read the article, “What To Know About Metformin: The Decades-Old Diabetes Drug Fueling Billions in Longevity Research,” here.
Learn more about the AFAR-managed TAME Trial here.
Explore a range of other articles on TAME featuring Dr. Barzilai and Dr. Sinclair here.
